Antibiotic resistance

Nursing Clinics of North America

Volumn 40, Issue 1, 2005, Pages 63-75

  Smith, Maria A ^a  

^a MIDDLE TENNESSEE STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; BACITRACIN; BETA LACTAM ANTIBIOTIC; CEPHALOSPORIN; CLINDAMYCIN; DALBAVANCIN; DALFOPRISTIN PLUS QUINUPRISTIN; DAPTOMYCIN; ERYTHROMYCIN; GENTAMICIN; LINEZOLID; NEOMYCIN; ORITAVANCIN; PENICILLIN G; RAMOPLANIN; STREPTOMYCIN; TELITHROMYCIN; TETRACYCLINE; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; ARTHRALGIA; BACTERIAL INFECTION; BACTERIAL STRAIN; BACTERIAL TRANSMISSION; CLINICAL TRIAL; DIARRHEA; DISINFECTION; DRUG APPROVAL; DRUG CONTROL; DRUG COST; DRUG LEGISLATION; DRUG MONITORING; DRUG SURVEILLANCE PROGRAM; DRUG USE; GRANULOCYTOPENIA; HAND WASHING; HEALTH CARE PERSONNEL; HUMAN; INFECTION CONTROL; INFECTION PREVENTION; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MYALGIA; NAUSEA; NURSING; PATIENT COMPLIANCE; PROTECTIVE CLOTHING; REVIEW; STREPTOCOCCUS PNEUMONIAE; THROMBOCYTOPENIA; VANCOMYCIN INTERMEDIATE STAPHYLOCOCCUS; VANCOMYCIN RESISTANT STAPHYLOCOCCUS AUREUS;

EID: 14744300161     PISSN: 00296465     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cnur.2004.08.006     Document Type: Review

References (26)

1. S.F. Dowell, S.M. Marcy, W.R. Phillips, M.A. Gerber, and B. Schwartz Principles of judicious use of antimicrobial agents for pediatric upper respiratory tract infections Pediatrics 101 Suppl 1 1998 163 165 Available at: http://www.cdc.gov/drugresistance/community/technical.htm Accessed January 17, 2004
2. A.D. Anderson, J.M. Nelson, S. Rossiter, and F.J. Angulo Public health consequences of use of antimicrobial agents in food animals in the United States Microb Drug Resist 9 4 2003 373 379 Available at: http://www.cdc.gov/narms/pub/ publications/a_anderson.pdf Accessed December 22, 2003
3. Skirble R. Abuse, overuse of antibiotics creates public health crisis. VOA News 2003;17:13. Available at: http://www.VOANews.com. Accessed December 10, 2003.
4. C.W. Stratton Dead bugs don't mutate: susceptibility issues in the emergence of bacterial resistance Emerg Infect Dis [serial online] 2003 Jan. Available at: http://www.cdc.gov/ncidod/EID/vol19no1/02-0175.htm Accessed January 3, 2004
5. M.L. Workman The cellular basis of bacterial infection Crit Care Nurs Clin North Am 15 1 2003 1 11
6. World Health Organization Factors contributing to resistance Infectious Disease Report 2000 Available at: http://www.who.int/infectious-disease-report/ 2000/ch3.htm Accessed December 1, 2003
7. Centers for Disease Control and Prevention. Antibiotic resistance: technical information. Available at: http://www.cdc.gov/drugresistance/ community/technical.htm. Accessed January 17, 2004.
8. Centers for Disease Control and Prevention. Department of Health and Human Services. Available at: http://www.cdc.gov. Accessed December 2, 2003.
9. Bren L. Battle of the bugs: fighting antibiotic resistance. FDA Magazine. Vol. 36, No. 4. July-August 2002. Available at: http://www.fda.gov/fdac/ features/2002/402_bugs.html. Accessed November 17, 2003.
10. I.S. Sanchez, M. Ramirez, H. Troni, M. Abecassis, M. Padua, and A. Tomasz Evidence for the geographic spread of a methicillin-resistant Staphylococcus-aureus clone between Portugal and Spain J Clin Microbiol 33 5 1995 1243 1246
11. M.I. Crisóstomo, H. Westh, A. Tomasz, M. Chung, D.C. Oliveira, and H. deLencaste The evolution of methicillin resistant Staphylococcus aureus: similarity of genetic backgrounds in historically early methicillin-susceptible and -resistant isolates and contemporary epidemic clones Proc Natl Acad Sci USA 17 1998 9865 9870
12. Centers for Disease Control and Prevention. Drug-resistant Streptococcus pneumonia disease. Available at: http://www.cdc.gov/ncidod/dbmd/diseaseinfo/ drugresistreppneum_t.htm. Accessed January 3, 2004.
13. C. Walsh Molecular mechanisms that confer antibacterial drug resistance Nature 406 2001 775 781
14. Centers for Disease Control and Prevention. The new drug development process: steps from test tube to new drug application review. Available at http://www.fda.gov/cder/handbook/develop.htm. Accessed April 2, 2004.
15. Food and Drug Administration. FDA Drug Approvals List. Available at: http://www.fda.gov/cder/foi/label/2003/21572_cubicin_lbl.pdf. Accessed January 8, 2004.
16. Genome Therapeutics Corporation. Ramoplanin: a novel antibiotic for serious bacterial infections. Available at http://www.genomecorp.com//programs/ pdf/RamoplaninBackgrounder.pdf. Accessed April 2, 2004.
17. D.T. Bearden, M.M. Neuhauser, and K.W. Garey Telithromycin: an oral ketolide for respiratory infections Pharmacotherapy 21 10 2001 1204 1222
18. S.M. Uriarte, R.E. Molestina, R.D. Miller, J. Bernabo, A. Farinati, and K. Eiguchi Effect of macrolide antibiotics on human endothelial cells activated by Chlamydia pneumonia infection and tumor necrosis factor J Infect Dis 185 2002 1631 1636
19. Department of Health and Human Services Food and Drug Administration. Labeling requirements for systemic and antibacterial drug products intended for human use Final rule 2003 21CFR Part 201. Available at: http://www.fda.gov/ OHRMS/DOCKETS/98fr/00n-1463-nfr00001.pdf
20. Centers for Disease Control and Prevention. Hand hygiene guidelines fact sheet. Available at: http://www.cdc.gov/od/oc/media/pressrel/fs021025.htm. Accessed December 22, 2003.
21. N. Singh, P. Rogers, C.W. Atwood, M.M. Wagener, and V.L. Yu Short course empiric antibiotic therapy for patients with pulmonary infiltrates in the intensive care unit. A proposed solution for indiscriminate antibiotic prescription A J Respir Crit Care Med 162 2 Pt 1 2000 505 511
22. Steinberg I. Clinical choices of antibiotics: Judging judicious use. Am J Manage Care 2000;6(23)(Suppl):S1178-88, S1241-2.
23. Timm E. Infection: antibiotics. Once daily aminoglycoside dosing in ICU patients. Presented at Program and Abstracts of the 32nd Critical Care Congress; San Antonio, January 28-February 2, 2003.
24. M.H. Kolef Is there a role for antibiotic cycling in the intensive care unit? Crit Care Med 29 Suppl 4 2001 N135 N142
25. B.D. Sommers Economics of antibiotic resistance Crit Care Nurs Clinic North Am 15 1 2003 89 96
26. R.A. Weinstein, and S.A. Kabins Strategies for prevention and control of multiple-drug resistant nosocomial infections Am J Med 70 1981 449 454